The HSE's report on its Valproate Response Project has been considered within my Department. The report describes the HSE's work on sodium valproate issues since the Valproate Response team was established in May 2018. This work has included the provision of an expert support service for people with concerns about exposure to sodium valproate; developing a diagnostic pathway for foetal valproate syndrome; and improving the structures in place to support families affected by valproate syndrome. The HSE has also begun the development of a Programme for Women's Health in Epilepsy, which will coordinate the national response to issues relating to sodium valproate.
I understand that the HSE intends to publish its report in the near future. My office is in contact with the relevant patient advocacy group to arrange a meeting.